This review highlights the need for and recent development of novel pharmacological and device-based approaches to improve blood pressure control in patients with hypertension.
Answers are grounded in this paper and cite their sources.
Supports development of novel hypertension therapies; leaves open their clinical adoption pending randomized data.
Uncontrolled blood pressure remains the single most common cause of death accounting for more than 7 million deaths per year worldwide. Despite the availability of potent lifestyle and pharmacologic approaches, rates of control of blood pressure are unsatisfactory and additional strategies to curb the burden of hypertension are warranted. Several novel pharmacological- and device-based approaches have recently been tested and may prove helpful to achieve better blood pressure control rates and thereby improve cardiovascular outcomes in patients with hypertension.
No takes yet. Share an insight, caveat, or question.
Hering et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: